Arjuna Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.72M | Sell |
3,439
-2,771
| -45% | -$1.33M | 0.39% | 68 |
|
|
2026
Q1 | $3.05M | Sell |
6,210
-373
| -6% | -$202K | 0.78% | 35 |
|
|
2025
Q4 | $3.81M | Buy |
6,583
+2,582
| +65% | +$1.46M | 0.93% | 24 |
|
|
2025
Q3 | $1.94M | Sell |
4,001
-4,188
| -51% | -$1.95M | 0.48% | 52 |
|
|
2025
Q2 | $3.32M | Sell |
8,189
-2,164
| -21% | -$905K | 0.88% | 26 |
|
|
2025
Q1 | $5.15M | Sell |
10,353
-6,531
| -39% | -$3.54M | 1.43% | 14 |
|
|
2024
Q4 | $8.78M | Buy |
16,884
+392
| +2% | +$216K | 2.34% | 10 |
|
|
2024
Q3 | $10.2M | Sell |
16,492
-125
| -0.8% | -$74K | 2.64% | 6 |
|
|
2024
Q2 | $9.19M | Buy |
16,617
+2,457
| +17% | +$1.41M | 2.47% | 7 |
|
|
2024
Q1 | $8.23M | Buy |
14,160
+592
| +4% | +$332K | 2.33% | 9 |
|
|
2023
Q4 | $7.2M | Buy |
13,568
+732
| +6% | +$354K | 2.25% | 10 |
|
|
2023
Q3 | $6.5M | Buy |
12,836
+485
| +4% | +$258K | 2.33% | 8 |
|
|
2023
Q2 | $6.44M | Buy |
12,351
+490
| +4% | +$264K | 2.28% | 7 |
|
|
2023
Q1 | $6.84M | Sell |
11,861
-478
| -4% | -$269K | 2.68% | 5 |
|
|
2022
Q4 | $6.79M | Buy |
12,339
+294
| +2% | +$156K | 3.13% | 6 |
|
|
2022
Q3 | $6.11M | Buy |
12,045
+39
| +0.3% | +$21.8K | 3% | 5 |
|
|
2022
Q2 | $6.52M | Buy |
12,006
+242
| +2% | +$133K | 3.16% | 5 |
|
|
2022
Q1 | $6.95M | Buy |
11,764
+379
| +3% | +$218K | 2.9% | 6 |
|
|
2021
Q4 | $7.6M | Buy |
11,385
+565
| +5% | +$353K | 2.78% | 9 |
|
|
2021
Q3 | $6.18M | Buy |
10,820
+470
| +5% | +$258K | 2.51% | 9 |
|
|
2021
Q2 | $5.22M | Buy |
10,350
+740
| +8% | +$349K | 2.26% | 9 |
|
|
2021
Q1 | $4.39M | Buy |
9,610
+574
| +6% | +$274K | 2.16% | 12 |
|
|
2020
Q4 | $4.21M | Buy |
9,036
+317
| +4% | +$149K | 2.33% | 8 |
|
|
2020
Q3 | $3.85M | Buy |
8,719
+1,746
| +25% | +$721K | 2.39% | 11 |
|
|
2020
Q2 | $2.53M | Buy |
6,973
+85
| +1% | +$28.5K | 1.74% | 15 |
|
|
2020
Q1 | $1.95M | Buy |
6,888
+227
| +3% | +$71.6K | 1.63% | 21 |
|
|
2019
Q4 | $2.16M | Buy |
6,661
+168
| +3% | +$50.9K | 1.57% | 22 |
|
|
2019
Q3 | $1.89M | Buy |
6,493
+144
| +2% | +$41.2K | 1.61% | 26 |
|
|
2019
Q2 | $1.86M | Buy |
6,349
+485
| +8% | +$134K | 1.34% | 28 |
|
|
2019
Q1 | $1.6M | Buy |
5,864
+3,106
| +113% | +$773K | 1.24% | 28 |
|
|
2018
Q4 | $617K | Sell |
2,758
-1
| -0% | -$235 | 0.56% | 54 |
|
|
2018
Q3 | $673K | Buy |
+2,759
| New | +$635K | 0.51% | 58 |
|
Other funds holding TMO
Arjuna Capital's TMO Position: Q2 2026 in Review
Arjuna Capital reduced its Thermo Fisher Scientific (TMO) stake by 45% in Q2 2026, selling an estimated $1.33M and leaving 3,439 shares worth $1.72M. The position accounts for 0.39% of the portfolio, ranked #68.
Arjuna Capital first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $10.2M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Arjuna Capital held 3,439 shares of Thermo Fisher Scientific worth $1.72M as of Q2 2026.
- Arjuna Capital sold 2,771 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.33M.
- Thermo Fisher Scientific made up 0.39% of Arjuna Capital's portfolio in Q2 2026, its #68 holding.
- Arjuna Capital first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- Arjuna Capital's Thermo Fisher Scientific position peaked at $10.2M in Q3 2024.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Arjuna Capital's 13F filing for Q2 2026, filed 14 Aug 2026.